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An increase in the prevalence of obesity in people with spinal cord injury can contribute to low-grade chronic inflammation and
increase the risk of infection in this population. A decrease in sympathetic activity contributes to immunosuppression due to the
lower activation of immune cells in the blood. The effects of physical exercise on inflammatory parameters in individuals with
spinal cord injury have not been well described. We conducted a review of the literature published from 1974 to 2012. This review
explored the relationships between low-grade inflammation, spinal cord injury, and exercise to discuss a novel mechanism that
might explain the beneficial effects of exercise involving an increase in catecholamines and cytokines in people with spinal cord
injury.
1. Background
Low-grade inflammation is an immune system response
that occurs when the body detects injurious stimuli. There
can be a neuroendocrine response, such as fever, a blood
response, and a metabolic response. White blood cells and
cytokines work together to fight against the injury. Inter-
leukins and tumor necrosis factor-alpha (TNF-𝛼) are impor-
tant cytokines that play a role in a wide variety of inflamma-
tory reactions. Wang et al. [1] demonstrated that spinal cord
injury was associated with increased serum concentrations
of C-reactive protein (CRP, a marker of inflammation in the
acute phase), interleukin 6 (IL-6), and endothelin-1. These
changes suggest that spinal cord injury, independent of
obesity, is associated with a state of chronic inflammation,
and this association may explain, at least in part, the increase
in the atherogenic risk in these patients [1].
With increasing age and time since injury, many individ-
uals with spinal cord injury have an inactive lifestyle, which
is associated with deconditioning and secondary health
conditions (e.g., osteoporosis, upper extremity pain, obesity,
diabetes, and cardiovascular disease), resulting in reduced
participation and quality of life [2]. An increase in the preva-
lence of obesity in people with spinal cord injury can further
contribute to low-grade chronic inflammation and increase
the risk of cardiovascular disease and type 2 diabetes in this
population [3]. Obesity is characterized by an excessive
increase in the amount of adipose tissue, which acts as an
organ secreting a large variety of proteins, including the pro-
inflammatory cytokines interleukin-6 (IL-6) and TNF-𝛼 [4].
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However, other factors in addition to obesity may con-
tribute to the development of low-grade chronic inflamma-
tion in this population. For example, spinal cord injury causes
a decrease in sympathetic activity, leading to significant
changes in the metabolism of carbohydrates and lipids,
such as decreased HDL cholesterol and increased insulin
resistance [5]. This decrease in sympathetic activity also con-
tributes to immunosuppression due to the lower activation of
immune cells in the blood.
Exercise is an important therapy for the rehabilitation of
individuals with spinal cord injury [6, 7]. This is the first to
simultaneously discuss the mechanisms related to low-grade
inflammation and spinal cord injury, andwe propose exercise
as a therapy. Our hypothesis is that exercise increases the
sympathetic system, causing an increase in catecholamines
and leading to enhanced lipolysis and the activation of
immune cells in the blood. These effects lead to a decrease in
body fat, particularly visceral fat, and the decreased produc-
tion of inflammatory cytokines by lymphocytes in blood,
leading to a decrease in the chronic inflammation found
during low-grade inflammation. Thus, the objective of this
work was to explore the relationships between low-grade
inflammation, spinal cord injury, and exercise to discuss a
novel mechanism that might explain the beneficial effects of
exercise, which may include an increase in catecholamines
and cytokines in people with spinal cord injury.
2. Methods
In this paper, we conducted a systematic and integrative
review of the literature using source articles indexed by the ISI
database, PubMed, and Medline by searching for books that
addressed specific aspects related to low-grade inflammation,
spinal cord injury, and exercise therapy which were published
between 1974 and 2012.
We used the following search terms: “inflammation and
spinal cord injury” (𝑛 = 1607), “inflammation and exercise”
(𝑛 = 3566), “inflammation and immune system” (𝑛 = 78611),
“spinal cord injury and cytokines” (𝑛 = 1087), “spinal cord
injury and obesity” (𝑛 = 154), and “spinal cord injury and exer-
cise” (𝑛 = 1787), for a total of 86812 articles. From this total,
we selected 72 articles that were specific to the present topic.
All the descriptors were searched by Boolean “or, and, not” to
obtain various arrangements to maximize the search and the
quality of research. No restrictions were made regarding age,
gender, or experimental design.
3. Spinal Cord Injury
Worldwide, the incidence of spinal cord injuries is 22 occur-
rences per million people [8]. In the United States, it is esti-
mated that spinal cord injury occurs in approximately 20% of
spinal fractures and that from 10 to 15% of patients pre-
senting with severe neurological damage have considerable
morbidity and a 5% mortality rate [7]. Because of the high
incidence and cost involved in the diagnosis, treatment, and
rehabilitation of these patients, spinal cord injury is a major
socioeconomic problem [9].
The term spinal cord lesion refers to any lesion that occurs
within the medullary canal of neural elements which results
in sensory,motor, and autonomic deficits.The individualmay
become paraplegic (injury between the lower thoracic verte-
brae and the lumbar spine) or quadriplegic (lesion in the high
thoracic or cervical spine) depending on the region of the
spinal injury. Paraplegic individuals have paralysis of the
lower limbs and difficulty in staying seated. In turn, tetraple-
gia is characterized by paralysis of all four extremities, upper
and lower, along the trunk musculature [10].
A spinal cord injury can be caused by trauma, viruses,
tumors, and schistosomiasis. Spinal cord injury is one of
the most debilitating injuries because it is characterized by
limited or no neurological recovery [8]. Several situations can
lead to spinal cord injury, including automobile accidents,
falls from heights, and injury by firearms and sports injuries
[8].
4. Spinal Cord Injury and
Low-Grade Inflammation
Spinal cord injury is a classic inflammatory process because
the pathophysiology of spinal cord injury is characterized by
disruption of the axons and cellmembranes, cell death, leuko-
cyte migration, and degradation of the myelin sheath [11, 12].
Factors such as an increase in the proinflammatory activity of
immune cells and toxic metabolites released from disrupted
cells may induce additional tissue damage. Previous studies
have demonstrated that alterations in the immune system in
individuals with spinal cord injury may further contribute to
a low-grade inflammatory process [13, 14]. Over time, indi-
viduals with spinal cord injury also exhibit chronic low-grade
inflammation [1]. Wang et al. [1] showed that injury itself was
associated with increased serum concentrations of C-reactive
protein (CRP, a marker of inflammation in the acute phase),
IL-6 and endothelin-1.These changes suggest that spinal cord
injury per se is associated with a state of chronic inflamma-
tion, which may explain, at least in part, the increase in the
atherogenic risk in these patients.
In addition to chronic low-grade inflammation, people
with spinal cord injury have lower fitness levels, decreased
total body leanmass, decreased energy expenditure, fat accu-
mulation in the lower limbs, and abdominal characteristics
that increase the risk of this population developing obesity
[15, 16].
5. Obesity and Inflammation
Obesity is characterized by an excessive increase in the
amount of adipose tissue [17], and it is a low-grade inflam-
matory disease. The adipose tissue acts as an organ secreting
a large variety of proteins, including the proinflammatory
cytokines interleukin-6 (IL-6) and TNF-𝛼 and the anti-
inflammatory proteins adiponectin and IL-10 [18, 19]. An
increase in the prevalence of obesity in spinal cord injury
patients can further contribute to low-grade chronic inflam-
mation, increasing the risk of cardiovascular disease in this
population [3]. Obesity contributes tometabolic dysfunction,
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including increases in circulating cytokines (IL-6, IL-1, and
TNF) [20], a decrease in protective factors, such as adipo-
nectin, and communication between cells in inflammatory
and metabolic diseases [21].
Cytokines are proteins that are produced and released
by different cells, including leukocytes, muscle cells, and
neurons. These proteins can act in a pleiotropic way or in
synergy with other substances and can modulate the pro-
duction of other cytokines [22]. Cytokines function in the
regulation of metabolism by influencing hormone secre-
tion, regulating Th1/Th2 immune responses, and inducing
inflammatory responses. In the nervous system, they regulate
complex neuronal actions and modulate thermoregulation,
food intake, and neurobiological patterns during sleep [23].
Interleukin-1 (IL-1) family members, such as IL-1𝛼, IL-1𝛽,
IL-1ra, and IL-18, are produced by various cells, such as lym-
phocytes, in response to inflammation produced by infection
and microbial endotoxins [24]. In addition, an increased IL-
1 plasma concentration may cause fever, sickness, increased
heart rate, increased blood flow in many vascular beds, and
increased sympathetic tone; changes in carbohydrate, fat, and
protein metabolism also occur [22–25].
TNF-𝛼 is mainly produced by macrophages and neu-
trophils, but other cells, such as lymphocytes, NK cells, endo-
thelial cells, and neural cells, might also have the capacity to
produce it [25]. TNF-𝛼 is produced in response to a wide
variety of stimuli, including infections and stimulation by
other cytokines or mitogens [24]. TNF-𝛼 is a potent pleio-
tropic cytokine due to its ability to activate multiple signal
transduction pathways and induce or suppress the expression
of a number of genes. In addition, it has potent endogenous
pyrogenic properties and may promote changes in the body’s
physiological temperature [26].Moreover, tissues that present
marked cachexia show high TNF-𝛼 activity, as observed
under catabolic conditions, such as cancer and systemic
inflammatory diseases [25].
Cytokines can penetrate the blood-brain barrier (BBB)
and act indirectly on the brain by stimulating the production
of chemical second messengers that carry information to tar-
gets, such as NF-𝜅B and adenosine [27–29]. The hypothesis
that cytokines could influence the functions of the nervous
system (NS) is based on observations that treatment with
cytokines, such as interferon-𝛾 (INF-𝛾), promotes neuroen-
docrine alterations. Other studies have identified receptors
for these cytokines in many areas of the brain [26, 30, 31].
Additional studies have shown that an increase in proin-
flammatory cytokine concentrations promotes a decrease in
the transendothelial electrical resistance and an increase in
the permeability of the BBB [32]. Finally, it is possible that
cytokinesmay be produced within the brain itself in response
to neuronal activity [22].
More recently, several studies have shown the existence
of an afferent neural pathway through which inflammation
in the peritoneal cavity might influence the brain [11]. Sub-
diaphragmatic transection of the vagus leads to fever reduc-
tion, poor sleep, nocturnal norepinephrine secretion, and
hypothalamic IL-1 production induced by lipopolysaccha-
rides (LPS) in the peritoneal cavity [32], thereby validating
this hypothesis. These alterations are not due to a reduction
in the circulating levels of cytokines or the attenuation of the
inflammatory response induced by lipopolysaccharide (LPS)
but rather to a defective translation of cytokines in the brain
[33].
6. Sympathetic Activity and Inflammation
Norepinephrine and epinephrine are key hormones that
prepare the body for one of its most primeval reactions: the
“fight or flight” response. Catecholamines increase the con-
tractility and conduction velocity of cardiomyocytes, leading
to increased cardiac output and an increase in blood pressure,
which leads to increased vascular tone and resistance. This
results in an increased “pre-load” in the right atrium, causing
the heart rate to drop due to the Starling mechanism.
Catecholamines also facilitate breathing (bronchi become
dilated) and mobilize the body’s metabolic reserves (lipolysis
and glycogenolysis) to provide vital energy [34].
Spinal cord-injured individuals with a cervical or high
thoracic lesion experience diminished sympathetic nerve
traffic below the level of injury [35], including reduced leg
sympathetic nerve activity recorded by microneurography
[36], decreased whole-body noradrenaline spillover [37], and
the impaired release of adrenaline from the adrenal medulla
[38]. Based on these findings, it can be hypothesized that not
only do these individuals experience a smaller increase in
overall sympathoadrenergic activity during arm exercise but
also the sympathetic activity in subcutaneous adipose tissue
will be less affected in areas proximal (e.g., the clavicular
region) to the injury than distal areas (e.g., the umbilical
region). Lower plasma catecholamine responses to arm exer-
cise have been found in individuals with spinal cord injury
compared with healthy subjects [39]. In accordance with
a differentiated autonomic response, hand heating elicits
perspiration above but not below the segmental level of
interrupted sympathetic output [40].
Catecholamines are the main regulators of lipolysis
plasma hormones in humans. Catecholamines regulate lipol-
ysis by stimulating 𝛼-adrenergic receptors and can therefore
decrease or increase lipolysis, depending on their concentra-
tion and binding affinity of the receptor. During exercise, the
increase in circulating catecholamines stimulates lipolysis by
activating the 𝛼-adrenergic receptor [41, 42].
The brain and the immune system are some of the body’s
major adaptive systems [34], and they communicate with
each other extensively in an attempt to regulate body homeo-
stasis [43]. Key systems involved in this crosstalk are the
hypothalamic-pituitary-adrenal (HPA) axis and the auto-
nomic nervous system, which consists of the adrenergic
sympathetic nervous system, the vagus-mediated parasym-
pathetic nervous system, and the enteric nervous system [34–
44]. Over many decades, an increasing body of evidence has
demonstrated that lymphocytes and phagocytes are capable
of synthesizing and releasing not only neuropeptides but also
neurotransmitters and hormones. Furthermore, these cells
have adrenergic and cholinergic functions. Thus, by coex-
isting in the nervous and immune system, these mediators
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become the universal language of the neuroendocrine-
immune-modulating network [45], which enables the ner-
vous, endocrine, and immune system to regulate and fine-
tune their functional responses positively or negatively,
thereby allowing the body to rapidly adapt to various changes
in internal and external environments.
We are now beginning to understand that catecholamines
are an integral part and potent modulators of these neuro-
endocrine-immune/inflammatory interactive networks.
Through direct communication via sympathetic nerve fibers
that innervate lymphoid organs [45], catecholamines can
modulate mouse lymphocyte proliferation and differentia-
tion [46] and the cytokine production of rodent.Th cells [47]
and human peripheral blood mononuclear cells (PBMCs)
[48].These interactions are facilitated by adrenergic receptors
expressed on murine lymphocytes [47], rat natural killer
(NK) cells [49], rodentmacrophages and neutrophils [50, 51],
and human PBMCs [52]. Consequently, we must better
understand the sources, distribution, and roles of catechola-
mines and their receptors in immunity and inflammation.
7. Exercise as an Anti-Inflammatory Therapy
A sedentary lifestyle is a risk factor for diseases, with several
clinical studies illustrating a reduction of mortality and
morbidity in physically active individuals compared to seden-
tary individuals [53, 54]. The effects of regular or chronic
exercise on basal levels of inflammatory markers have been
used to recommend exercise as an anti-inflammatory ther-
apy. According to Kasapis and Thompson [55], a single
session of exercise triggers an increase in proinflammatory
cytokine release, which is associated with leukocytosis and an
increased plasma concentration of CRP. This proinflamma-
tory response to acute exercise is accompanied by a sudden
increase in oxidative stress, followed by adaptivemechanisms
against inflammation [56].
Moreover, a longitudinal study showed that regular
training induces a reduction in C-reactive protein levels,
suggesting anti-inflammatory action, under several condi-
tions, including insulin resistance and other cardiovascu-
lar/cardiometabolic diseases. Regular exercise is also asso-
ciated with decreased IL-6 and TNF-𝛼 and an increase in
anti-inflammatory substances, such as IL-4 and IL-10 [57],
reinforcing the anti-inflammatory nature of exercise [58, 59].
Cytokines are released from not only mononuclear cells
but also muscle cells. Starkie et al. showed that physical exer-
cise directly inhibits endotoxin-induced TNF-𝛼 production
in humans, most likely through IL-6 release from exercising
muscle [60]. Typically, IL-6 is the first cytokine present in
circulation after exercise, followed by an increase in IL-1ra
and IL-10 [61]. IL-6 release depends on the intensity and
duration of exercise and is directly related to the concentra-
tion of catecholamines in the blood. The role of IL-6 and
the hypothesis of exercise-induced anti-inflammatory IL-6
release has been recently reviewed [62, 63]. Therefore, IL-6,
a multifactorial cytokine, regulates cellular and humoral
responses and plays a pivotal role in inflammation, being
associated with several pathological conditions as a marker
of low-grade inflammation [62, 63]. However, what is even
more interesting concerning IL-6, as Fisman and Tenenbaum
[62] commented, are the putative beneficial effects it has as
an anti-inflammatory factor, which is particularly evident in
insulin sensitivity during exercise.
A marked increase in circulating levels of IL-6 after exer-
cise withoutmuscle damage has been a remarkably consistent
finding. The magnitude by which plasma IL-6 increases is
related to exercise duration, the intensity of effort, the muscle
mass involved in themechanical work, and endurance capac-
ity [63] IL-6 has been indicated as the strongest candidate
for a humoral factor released after exercise, working in a
hormone-like fashion, in which it is released by the muscle,
now viewed as an endocrine organ, to influence other organs
[63]. Due to its capacity to stimulate the hypothalamus-
pituitary-adrenal axis to produce adrenaline, cortisol and
anti-inflammatory cytokines, such as interleukin-4 (IL-4)
and interleukin-10 (IL-10), IL-6 also has anti-inflammatory
properties [25].
IL-10 was described as a product of lymphocytes that
might inhibit Th1 cytokine production. The IL-10 family
consists of five other less-studied cytokines: interleukin-19
(IL-19), interleukin-20 (IL-20), interleukin-22 (IL-22), inter-
leukin-24 (IL-24), and interleukin-26 (IL-26). Several tissues
may function as sources of IL-10, including lymphocytes and
adipose and skeletal muscle. Additionally, IL-10 has multiple
biological activities and affects many different cell types,
including monocytes/macrophages, T cells, B cells, NK cells,
neutrophils, endothelial cells, and peripheral bloodmononu-
clear cells (PBMCs). IL-10 also acts in the regulation of
inflammation because it is produced by adipose and muscle
tissues, which are important to the pro-/anti-inflammatory
ratio under conditions such as physical exercise, obesity, and
inflammatory diseases [64, 65].
8. Can Physical Exercise Improve
Inflammation in Spinal Cord Injuries?
The protective effect of exercise against diseases associated
with chronic inflammation may, to some extent, be ascribed
to anti-inflammatory activity. Several studies have shown
that markers of inflammation are reduced following longer-
term behavioral changes involving reduced energy intake and
increased physical activity [58]. The data presented in that
study highlighted the idea that the beneficial effect of exercise
seems to be related to its ability to decrease inflammatory
cytokine levels and/or increase anti-inflammatory cytokines,
which might also be true for pathological conditions and
physical limitations, such as spinal cord injury.
In a recent review, Martin et al. [66] showed consistent
evidence that exercise and physical training are effective in
improving the physical fitness of people with spinal cord
injury. These benefits were dependent on the time, inten-
sity, and volume of exercise [66]. Regarding the effects of
physical activity, some studies have shown that exercise can
promote anti-inflammatory effects. Petersen and Pedersen
[59] showed that, in healthy subjects, exercise induced the
release of IL-6, which is primarily synthesized in muscle
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fibers and can be released into the blood stream to stimulate
the circulation of other anti-inflammatory cytokines, such
as receptor antagonist IL-1 (IL-1RA) and IL-10, and inhibit
the production of the proinflammatory cytokine TNF-𝛼.
Furthermore, IL-6 stimulates lipolysis and fat oxidation, and,
after exercise, its concentration will depend mainly on the
duration and intensity of exercise performed [67].
Considering the factors mentioned above, we believe that
acute exercise causes an increase in sympathetic activity, and
this response is intensity dependent, causing an increase
in plasma catecholamines and other hormones, thereby
modulating the neuro-immuno-endocrine axis in individuals
with spinal cord injury. Thus, it is suggested that increasing
catecholamines through physical exercise leads to enhanced
lipolysis and the activation of immune cells in the blood.
These effects lead to a decrease in body fat, particularly
visceral fat, and a decreased production of inflammatory
cytokines by lymphocytes in the blood, leading to a decrease
in the low-grade inflammation found in this population [59,
68–70].
9. Conclusions
The relationships between low-grade inflammation, spinal
cord injury, and exercise as therapy are discussed in the
present review. Individuals with spinal cord lesions have a
higher risk for obesity and, consequently, low-grade chronic
inflammation due to the accumulation of visceral fat and
the subsequent increased production of proinflammatory
cytokines by adipose tissue. Additionally, the decrease in
sympathetic activity observed in this population leads to an
attenuation of lipolysis, dyslipidemia, and increased macro-
phage infiltration in adipose tissue, which contribute to
chronic inflammation.
In contrast, acute exercise causes an intensity-dependent
increase in sympathetic activity, leading to an increase in
plasma catecholamines and a subsequent increase in IL-6 in
the blood. This IL-6 release into the circulation after exercise
is followed by an increase in IL-1ra and IL-10 anti-inflam-
matory cytokines. This increase in sympathetic response
leads to enhanced lipolysis and the activation of immune
cells in the blood. These effects lead to a decrease in body
fat, particularly visceral fat, and the decreased production
of inflammatory cytokines by lymphocytes in the blood.
Given the evidence cited in the study, we conclude that
exercise could be an interesting nonpharmacological therapy
to decrease chronic low-grade inflammation.
In this sense, we believe that exercise could be considered
a modulator of the neuro-immuno-endocrine axis in spinal
cord injury patients, acting as a potential option to improve
the quality of life in these individuals.
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